Characterization of the newly proposed HIV-1 lineage within subtype A, sub-subtype A7 - Maja Lunar

European Meeting on HIV & Hepatitis 2021

Association of APOBEC3 activity in HIV-1 DNA with non-B HIV-1 and low HIV-1 reservoir - Basma ABDI

European Meeting on HIV & Hepatitis 2021

Epidemiology and transmission of drug resistance mutations among treatment-naïve people living with HIV-1 in Israel, 2010-2018 - Tali Wagner

European Meeting on HIV & Hepatitis 2021

Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019 - Karol Serwin

European Meeting on HIV & Hepatitis 2021

Assessment of HIV-1 DNA quantification methods in the Italian HIV DNA Network - Ilaria Vicenti

European Meeting on HIV & Hepatitis 2021

Nervous system pathology of HIV-positive people in the large industrial center within the Russian Federation: epidemiological analysis - Viktoria Sotskova

European Meeting on HIV & Hepatitis 2021

AIDS mortality and lethality in Minsk, Belarus - Marharyta Shylava

European Meeting on HIV & Hepatitis 2021

Co-infections with hepatitis virus B and C among patients with human immunodeficiency virus in a regional center of HIV/AIDS from northeastern Romania - Cristina Sapaniuc

European Meeting on HIV & Hepatitis 2021

Molecular Epidemiology Analysis Reveals Actively Growing Transmission Clusters in the Polyphyletic HIV-1 Infection in Cyprus (2019-2020) - Cicek Topcu

European Meeting on HIV & Hepatitis 2021

Hepatitis C virus treatment response to sofosbuvir/ledipasvir among adolescents coinfected with HIV and HCV: Real world data from Ukraine - Farihah Malik

European Meeting on HIV & Hepatitis 2021

Pharmacist-led telephone clinic is an effective strategy for treating patients with hepatitis C and removing barriers to attending appointments - Andrew Sommerville

European Meeting on HIV & Hepatitis 2021

Frequency of IN gene region polymorphisms associated with ALLINIs effectiveness in HIV-1 subtype A6 dominating in Russia - Ilya Lapovok

European Meeting on HIV & Hepatitis 2021

Pretreated drug-resistance in newly diagnosed HIV-1 patients in Portugal between 2014 and 2019 - Marta Pingarilho

European Meeting on HIV & Hepatitis 2021

Application of the genetic diversity analysis for determination of HIV infection duration - Anastasia Murzakova

European Meeting on HIV & Hepatitis 2021

Integrase genotyping is highly effective on diverse HIV-1 non-B clades circulating in Cameroon: toward a successful transition to Dolutegravir-based regimens in Africa - Ezechiel Ngoufack Jagni Semengue

European Meeting on HIV & Hepatitis 2021

Comparison of the new Cepheid HIV VL XC Assay with the established Abbott Alinity m in HIV-1 viral load measurement - Robert Ehret

European Meeting on HIV & Hepatitis 2021

A Public Health Approach to Sustainability of Community Based HCV Treatment among HIV/HCV Co-infected KPs through programmatic cost efficiency in Ukraine - Zahedul Islam

European Meeting on HIV & Hepatitis 2021

Sensitivity of ultra-deep sequencing for dual HIV infection detection - Darya Saleeva

European Meeting on HIV & Hepatitis 2021

A Multi-Allelic Molecular-Beacon-Based Real-Time RT-PCR Assay for the Detection of the Coronavirus SARS-CoV-2 from Clinical Samples - Andreas Chrysostomou

European Meeting on HIV & Hepatitis 2021

Use of Fibroquel® (type I polymerized collagen) in patients with hypoxemic inflammatory pneumonia secondary to COVID-19 in Veracruz, Mexico. - Luis Del Carpio-Orantes

European Meeting on HIV & Hepatitis 2021

PK-virological algorithm to target risk of resistance among key populations in Togo - Valentine Ferré

European Meeting on HIV & Hepatitis 2021

Longitudinal Evaluation of Sequencing Quality in EQA-Schemes from 2014 to 2020 - Marcel Schuetze

European Meeting on HIV & Hepatitis 2021